The article reports that C-polysaccharide is a phosphocholine-substituted ribitol teichoic acid and, in 1971, Volanakis and Kaplan identified phosphocholine as the structure to which CRP binds. Topics incldue considered that CRP bound to C-polysaccharide and other ligands, and activated the classical complement pathway, and showed that CRP was thereby capable of mediating inflammation.